Your browser doesn't support javascript.
loading
Invasive device-associated infections caused by Pseudomonas aeruginosa in critically ill patients: evolution over 10 years.
Álvarez-Lerma, F; Olaechea-Astigarraga, P; Palomar-Martínez, M; Catalan, M; Nuvials, X; Gimeno, R; Gracia-Arnillas, M P; Seijas-Betolaza, I.
Afiliação
  • Álvarez-Lerma F; Service of Intensive Care Medicine, Hospital del Mar, Barcelona, Spain; Universitat Autònoma de Barcelona, Barcelona, Spain; Research Group in Critical Disorders (GREPAC), Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Barcelona, Spain. Electronic address: Falvarez@parcdesalutmar.cat.
  • Olaechea-Astigarraga P; Service of Intensive Care Medicine, Hospital Galdakao-Usansolo, Bizkaia, Spain.
  • Palomar-Martínez M; Intensive Care Unit, Hospital Universitari Arnau de Vilanova, Lleida, Spain.
  • Catalan M; Service of Intensive Care Medicine, Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Nuvials X; Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Gimeno R; Service of Intensive Care Medicine, Hospital Universitario la Fe, Valencia, Spain.
  • Gracia-Arnillas MP; Service of Intensive Care Medicine, Hospital del Mar, Barcelona, Spain; Research Group in Critical Disorders (GREPAC), Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Barcelona, Spain.
  • Seijas-Betolaza I; Service of Intensive Care Medicine, Hospital de Cruces, Barakaldo, Bizkaia, Spain.
J Hosp Infect ; 100(3): e204-e208, 2018 Nov.
Article em En | MEDLINE | ID: mdl-29751023
ABSTRACT
Invasive device-associated infections caused by Pseudomonas aeruginosa over 10 years (2007-2016) were assessed based on data from the ENVIN-HELICS registry (200 Spanish intensive care units). P. aeruginosa was the leading pathogen except in the last two years in which there was a slight decrease, with Escherichia coli as the leading aetiology. The rate of infections caused by P. aeruginosa remained between 12.0% and 14.6% throughout the study period. There was a significant increase of isolates resistant to imipenem, meropenem, ceftazidime, cefepime, and piperacillin-tazobactam. Multidrug-resistant and the sum of extensively drug- and pandrug-resistant strains also increased. Resistance to anti-pseudomonal antimicrobials remains a matter of concern.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por Pseudomonas / Infecção Hospitalar / Estado Terminal / Infecções Relacionadas a Cateter Tipo de estudo: Clinical_trials / Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Europa Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por Pseudomonas / Infecção Hospitalar / Estado Terminal / Infecções Relacionadas a Cateter Tipo de estudo: Clinical_trials / Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Europa Idioma: En Ano de publicação: 2018 Tipo de documento: Article